Destiny Pharma announce publication of XF-73 drug synergy data
MarketScreener,
Brighton, United Kingdom - (AIM: DEST), a clinical stage biotechnology company focused on the development of novel products to…
Brighton, United Kingdom - (AIM: DEST), a clinical stage biotechnology company focused on the development of novel products to…
07/07/2022 - 4 minutes Image: Shutterstock New data has been published today (July 7) evidencing findings that could lead to…
Destiny Pharma has announced the publication of new data on XF-73, which is shown to enhance the activity of two antibacterial…
XF-73 shown to enhance the activity of two antibacterial drugs Findings may lead to improved treatments for lethal lung…